MoneyWorks4Me

Kilitch Drugs(India) - Quaterly Results

13 Aug 2025 Evaluate
The company's total revenue for the quarter ended June 2025 saw a slight change in the total revenue, having registered a total revenue of Rs. 341.22 millions.A humble growth in net profit of 18.23% reported in the quarter ended June 2025 to Rs. 47.93  millions from Rs. 40.54 millions.Operating Profit saw a handsome growth to 70.67 millions from 64.31 millions in the quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 341.22 334.22 2.09 341.22 334.22 2.09 1815.87 1315.99 37.99
Other Income 34.95 32.12 8.81 34.95 32.12 8.81 137.15 61.89 121.60
PBIDT 70.67 64.31 9.89 70.67 64.31 9.89 445.53 265.06 68.09
Interest 5.87 4.90 19.80 5.87 4.90 19.80 21.26 19.08 11.43
PBDT 64.80 59.41 9.07 64.80 59.41 9.07 424.27 245.98 72.48
Depreciation 4.99 3.49 42.98 4.99 3.49 42.98 17.37 12.44 39.63
PBT 59.81 55.92 6.96 59.81 55.92 6.96 406.90 233.54 74.23
TAX 11.88 15.38 -22.76 11.88 15.38 -22.76 95.33 57.79 64.96
Deferred Tax -1.11 2.73 -140.66 -1.11 2.73 -140.66 -3.17 -5.86 -45.90
PAT 47.93 40.54 18.23 47.93 40.54 18.23 311.57 175.75 77.28
Equity 160.82 160.82 0.00 160.82 160.82 0.00 160.82 160.82 0.00
PBIDTM(%) 20.71 19.24 7.64 20.71 19.24 7.64 24.54 20.14 21.82
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..